Advanced search
Publication Cover
OncoImmunology Volume 6, 2017 - Issue 3
Submit an article Journal homepage
4,967
Views
112
CrossRef citations to date
0
Altmetric
Original research

Assessment of tumor-infiltrating TCRVγ9Vδ2 γδ lymphocyte abundance by deconvolution of human cancers microarrays

Marie TosoliniCentre de Recherches en Cancérologie de Toulouse (CRCT), Toulouse, France;INSERM U1037-Université Paul Sabatier-CNRS ERL5294, Université de Toulouse, Toulouse, France;Laboratoire d'Excellence TOUCAN, Toulouse, France;Programme Hospitalo-Universitaire en Cancérologie CAPTOR, Toulouse, France;Pôle Technologique du Centre de Recherches en Cancérologie de Toulouse (CRCT), Toulouse, France;Institut Universitaire du Cancer de Toulouse (IUCT), Toulouse, FranceORCID Iconhttp://orcid.org/0000-0001-5278-5952
ORCID Icon,
Frédéric PontCentre de Recherches en Cancérologie de Toulouse (CRCT), Toulouse, France;INSERM U1037-Université Paul Sabatier-CNRS ERL5294, Université de Toulouse, Toulouse, France;Pôle Technologique du Centre de Recherches en Cancérologie de Toulouse (CRCT), Toulouse, France
,
Mary PoupotCentre de Recherches en Cancérologie de Toulouse (CRCT), Toulouse, France;INSERM U1037-Université Paul Sabatier-CNRS ERL5294, Université de Toulouse, Toulouse, France;Laboratoire d'Excellence TOUCAN, Toulouse, France;Programme Hospitalo-Universitaire en Cancérologie CAPTOR, Toulouse, France
,
François VergezCentre de Recherches en Cancérologie de Toulouse (CRCT), Toulouse, France;INSERM U1037-Université Paul Sabatier-CNRS ERL5294, Université de Toulouse, Toulouse, France;Institut Universitaire du Cancer de Toulouse (IUCT), Toulouse, France
,
Marie-Laure Nicolau-TraversInstitut Universitaire du Cancer de Toulouse (IUCT), Toulouse, France
,
David VermijlenDepartment of Biopharmacy and Institute for Medical Immunology (IMI), Université Libre de Bruxelles, Bruxelles, Belgium
,
Jean- Emmanuel SarryCentre de Recherches en Cancérologie de Toulouse (CRCT), Toulouse, France;INSERM U1037-Université Paul Sabatier-CNRS ERL5294, Université de Toulouse, Toulouse, France;Programme Hospitalo-Universitaire en Cancérologie CAPTOR, Toulouse, France
,
Francesco DieliCentral Laboratory for Advanced Diagnostics and Biomedical Research (CLADIBIOR), University of Palermo, Palermo, Italy
&
Jean-Jacques FourniéCentre de Recherches en Cancérologie de Toulouse (CRCT), Toulouse, France;INSERM U1037-Université Paul Sabatier-CNRS ERL5294, Université de Toulouse, Toulouse, France;Laboratoire d'Excellence TOUCAN, Toulouse, France;Programme Hospitalo-Universitaire en Cancérologie CAPTOR, Toulouse, FranceCorrespondence[email protected]
ORCID Iconhttp://orcid.org/0000-0001-6542-6908
ORCID Icon show all
Article: e1284723 | Received 22 Dec 2016, Accepted 13 Jan 2017, Published online: 30 Mar 2017

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.